Amantadine Hcl
Brand name: Amantadine
Rank #270 of 500 drugs by total cost
$45.2M
Total Cost
173,840
Total Claims
$45.2M
Total Cost
6,009
Prescribers
$260
Cost per Claim
17,808
Beneficiaries
252,270
30-Day Fills
$7,525
Avg Cost/Provider
29
Avg Claims/Provider
About Amantadine Hcl
Amantadine Hcl (sold as Amantadine) was prescribed 173,840 times by 6,009 Medicare Part D providers in 2023, costing the program $45.2M. At $260 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 267 | C1 Esterase Inhibitor (Haegarda) | $45.8M | 894 |
| 268 | Alectinib Hcl (Alecensa) | $45.7M | 2,686 |
| 269 | Ipratropium Bromide (Ipratropium Bromide) | $45.4M | 656,249 |
| 270 | Amantadine Hcl (Amantadine) | $45.2M | 173,840 |
| 271 | Insulin Nph Human Isophane (Humulin N) | $44.9M | 172,714 |
| 272 | Bosutinib (Bosulif) | $44.9M | 2,962 |
| 273 | Tramadol Hcl (Tramadol Hcl) | $44.9M | 5,226,406 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology